drugset / Trial / NCT06994117
Summary
This is an expanded access designed to provide access to Mezigdomide for eligible participants.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Mezigdomide | Small molecule | — | — |
Indications
No indication recorded.